ZYBERNO
Stock Report
Updated Sep 1, 2026

AETHLON MEDICAL, INC. (AEMD)

Healthcare • NASDAQ

$1.91

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
14.0/100
POOR BUSINESS
AETHLON MEDICAL, INC. (AEMD) scores 14/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-123.1%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.10x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-684.4%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

AETHLON MEDICAL, INC. (AEMD) stock report — Zyberno Score 14/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:1.91
Market Cap:$734.79K

Valuation Multiples (2)

P/B Ratio:0.14x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:-$3.69M

Price Action & Momentum (1)

% of 52-Week High:2.1%
B. Profitability Assessment

Return Metrics (5)

ROA:-99.3%
Reinvestment Rate:6.0%
Fundamental Growth Rate (g):-41.2%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$486.93
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-342.4%
Latest Earnings Filed:2026-08-13
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:5.42x
Quick Ratio:5.42x
Cash Ratio:4.76x

Leverage Analysis (3)

Debt To Equity Ttm:0.10x
Debt-to-Equity Ratio:0.10x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-74.41x
Times Interest Earned:-74.41

Capital Structure (4)

Working Capital:4,574,872.00
Cash And Cash Equivalents:4,933,579.00
Long Term Debt:$255.05K
Net Debt:-$4.42M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$7.08M

Bottom Line Performance (3)

-$6.94M
Income Before Tax:-$7.15M
Ebitda Ttm:-6,766,567.00

Operating Expenses (5)

Operating Expenses:7,080,443.00
R And D Expense:1,936,632.00
Sga Expense:2,623,537.00
Income Tax Expense:$0.00
Interest Expense:98,016.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$6.24M
Current Assets:$5.61M
Ppe Net:293,112.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:1,446,835.00
Current Liabilities:1,036,042.00
Long Term Debt:$255.05K
Short Term Debt:$255.05K

Equity & Capital (3)

Equity:$5.20M
Retained Earnings:-$176.65M
Common Stock:20,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:411,373.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:50,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$7.18M-$7.00M

Investment Activities (1)

Investing Cash Flow:-$9.15K

Financing Activities (3)

Financing Cash Flow:$1.82M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:1,904,211.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:313,876.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-13.78
-$13.78
Earnings Per Share Ttm:-$18.03

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$18.19

Book Value & Capital (2)

Book Value Per Share:$13.52
Cash Per Share:12.82

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:6.0%
Fundamental Growth Rate (g):-41.2%
B. Log-Linear Regression Growth Analysis

Other Growth Rates (1)

Book Value Growth Rate (Linear):-31.2%
C. Company Profile & Context

Corporate Information (6)

Symbol:AEMD
Company Name:AETHLON MEDICAL, INC.
Sector:Healthcare
Industry:Medical Devices
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:384.71K
Shares Outstanding Basic:384.71K
Shares Outstanding Diluted:384.71K

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 19:16:14 UTC
Data Timestamp:2026-08-22T06:13:18.699927
Scroll to Top